相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Comorbidity in young patients with juvenile systemic lupus erythematosus: how can we improve management?
Coziana Ciurtin et al.
CLINICAL RHEUMATOLOGY (2022)
Cardiovascular Health in Pediatric Rheumatologic Diseases
Kaveh Ardalan et al.
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2022)
Metabolomics Defines Complex Patterns of Dyslipidaemia in Juvenile-SLE Patients Associated with Inflammation and Potential Cardiovascular Disease Risk
George A. Robinson et al.
METABOLITES (2022)
Challenges in Implementing Cardiovascular Risk Scores for Assessment of Young People With Childhood-Onset Autoimmune Rheumatic Conditions
Coziana Ciurtin et al.
FRONTIERS IN MEDICINE (2022)
mTOR inhibitor improves testosterone-induced myocardial hypertrophy in hypertensive rats
Jianshu Chen et al.
JOURNAL OF ENDOCRINOLOGY (2022)
Lipid metabolism in autoimmune rheumatic disease: implications for modern and conventional therapies
George Robinson et al.
JOURNAL OF CLINICAL INVESTIGATION (2022)
Triglyceride-Rich Lipoprotein Remnants and Cardiovascular Disease
Edward K. Duran et al.
CLINICAL CHEMISTRY (2021)
Menopausal Hormone Therapy and Cardiovascular Disease: The Role of Formulation, Dose, and Route of Delivery
Chrisandra L. Shufelt et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)
Cardiovascular risk and testosterone - from subclinical atherosclerosis to lipoprotein function to heart failure
Baris Gencer et al.
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2021)
Sex Hormones and Gender Influence the Expression of Markers of Regulatory T Cells in SLE Patients
Ram P. Singh et al.
FRONTIERS IN IMMUNOLOGY (2021)
Women's cardiovascular health: shifting towards equity and justice
Ana Olga Mocumbi
LANCET (2021)
The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030
Birgit Vogel et al.
LANCET (2021)
Sex hormones drive changes in lipoprotein metabolism
George A. Robinson et al.
ISCIENCE (2021)
The Prevalence of Autoimmune Disorders in Women: A Narrative Review
Fariha Angum et al.
CUREUS JOURNAL OF MEDICAL SCIENCE (2020)
Sex differences in clinical presentation of systemic lupus erythematosus
Jorge I. Ramirez Sepulveda et al.
BIOLOGY OF SEX DIFFERENCES (2019)
Cardiovascular Risks Associated with Gender and Aging
Jennifer L. Rodgers et al.
JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE (2019)
mTOR Inhibition and Cardiovascular Diseases: Dyslipidemia and Atherosclerosis
Ammar Kurdi et al.
TRANSPLANTATION (2018)
Role of mTOR in Glucose and Lipid Metabolism
Zhuo Mao et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Lipids, Lipoproteins, and Metabolites and Risk of Myocardial Infarction and Stroke
Michael V. Holmes et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Sirolimus in patients with clinically active systemic lupus erythematosus resistant to, or intolerant of, conventional medications: a single-arm, open-label, phase 1/2 trial
Zhi-Wei Lai et al.
LANCET (2018)
The Representation of Gender and Race/Ethnic Groups in Randomized Clinical Trials of Individuals with Systemic Lupus Erythematosus
Titilola Falasinnu et al.
CURRENT RHEUMATOLOGY REPORTS (2018)
Lipid profile among girls with systemic lupus erythematosus
Daniele Machado et al.
RHEUMATOLOGY INTERNATIONAL (2017)
Dyslipidemia in systemic lupus erythematosus
Melinda Zsuzsanna Szabo et al.
IMMUNOLOGIC RESEARCH (2017)
Cross-Sex Hormones and Metabolic Parameters in Adolescents With Gender Dysphoria
Jason Jarin et al.
PEDIATRICS (2017)
mTOR Signaling in Growth, Metabolism, and Disease
Robert A. Saxton et al.
CELL (2017)
Sex- and tissue-specific changes in mTOR signaling with age in C57BL/6J mice
Emma L. Baar et al.
AGING CELL (2016)
Activation of mTOR (mechanistic target of rapamycin) in rheumatic diseases
Andras Perl
NATURE REVIEWS RHEUMATOLOGY (2016)
Cardiovascular Disease in Women: Clinical Perspectives
Mariana Garcia et al.
CIRCULATION RESEARCH (2016)
Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease New Insights From Epidemiology, Genetics, and Biology
Borge G. Nordestgaard
CIRCULATION RESEARCH (2016)
Effects of hormonal contraception on systemic metabolism: cross-sectional and longitudinal evidence
Qin Wang et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2016)
Recent Advances in Adipose mTOR Signaling and Function: Therapeutic Prospects
Huan Cai et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2016)
An Essential Role for Liver ERα in Coupling Hepatic Metabolism to the Reproductive Cycle
Sara Della Torre et al.
CELL REPORTS (2016)
Sex differences in immune responses
Sabra L. Klein et al.
NATURE REVIEWS IMMUNOLOGY (2016)
The Roles of mTOR Complexes in Lipid Metabolism
Alexandre Caron et al.
ANNUAL REVIEW OF NUTRITION, VOL 35 (2015)
Coronary Heart Disease Mortality Declines in the United States From 1979 Through 2011 Evidence for Stagnation in Young Adults, Especially Women
Kobina A. Wilmot et al.
CIRCULATION (2015)
Impaired serum cholesterol efflux capacity in rheumatoid arthritis and systemic lupus erythematosus
Nicoletta Ronda et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Very low density lipoprotein cholesterol associates with coronary artery calcification in type 2 diabetes beyond circulating levels of triglycerides
Stuart B. Prenner et al.
ATHEROSCLEROSIS (2014)
Cross-Sex Hormone Therapy in Trans Persons Is Safe and Effective at Short-Time Follow-Up: Results from the European Network for the Investigation of Gender Incongruence
Katrien Wierckx et al.
JOURNAL OF SEXUAL MEDICINE (2014)
Energy metabolism and fertility-a balance preserved for female health
Sara Della Torre et al.
NATURE REVIEWS ENDOCRINOLOGY (2014)
Elevated Remnant Cholesterol Causes Both Low-Grade Inflammation and Ischemic Heart Disease, Whereas Elevated Low-Density Lipoprotein Cholesterol Causes Ischemic Heart Disease Without Inflammation
Anette Varbo et al.
CIRCULATION (2013)
Sex-Specific mTOR Signaling Determines Sexual Dimorphism in Myocardial Adaptation in Normotensive DOCA-Salt Model
Dennis Guergen et al.
HYPERTENSION (2013)
Cardiovascular risk in pediatric-onset rheumatological diseases
Julie Barsalou et al.
ARTHRITIS RESEARCH & THERAPY (2013)
mTOR Signaling in Growth Control and Disease
Mathieu Laplante et al.
CELL (2012)
Regulation of hepatic LDL receptors by mTORC1 and PCSK9 in mice
Ding Ai et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010
Rafael Lozano et al.
LANCET (2012)
Tetradian oscillation of estrogen receptor α is necessary to prevent liver lipid deposition
Alessandro Villa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Rapamycin Reverses Elevated mTORC1 Signaling in Lamin A/C-Deficient Mice, Rescues Cardiac and Skeletal Muscle Function, and Extends Survival
Fresnida J. Ramos et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
mTOR Complex 1 Regulates Lipin 1 Localization to Control the SREBP Pathway
Timothy R. Peterson et al.
CELL (2011)
Heart Disease and Stroke Statistics-2011 Update A Report From the American Heart Association
Veronique L. Roger et al.
CIRCULATION (2011)
Estrogen Signaling and Cardiovascular Disease
Elizabeth Murphy
CIRCULATION RESEARCH (2011)
Lipid parameters for measuring risk of cardiovascular disease
Benoit J. Arsenault et al.
NATURE REVIEWS CARDIOLOGY (2011)
Childhood-Onset Disease as a Predictor of Mortality in an Adult Cohort of Patients With Systemic Lupus Erythematosus
Aimee O. Hersh et al.
ARTHRITIS CARE & RESEARCH (2010)
Premature Atherosclerosis in Pediatric Systemic Lupus Erythematosus
Laura E. Schanberg et al.
ARTHRITIS AND RHEUMATISM (2009)
Heart Disease and Stroke Statistics-2009 Update A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Donald Lloyd-Jones et al.
CIRCULATION (2009)
Dyslipidaemia and lipoprotein pattern in systemic lupus erythematosus (SLE) and SLE-related cardiovascular disease
X. Hua et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2009)
Accumulation of coronary artery disease risk factors actors over three years:: Data from an international inception cohort
M. B. Urowitz et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2008)
Prevention of atherosclerosis by the mTOR inhibitor everolimus in LDLR-/- mice despite severe hypercholesterolemia
Marc A. Mueller et al.
ATHEROSCLEROSIS (2008)
Lipoprotein subclasses and particle size determined by nuclear magnetic resonance spectroscopy in systemic lupus erythematosus
Cecilia P. Chung et al.
CLINICAL RHEUMATOLOGY (2008)
Signaling by Estrogens
Boris J. Cheskis et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2007)
Clinical manifestations and coronary artery disease risk factors at diagnosis of systemic lupus erythematosus: data from an international inception cohort
M. B. Urowitz et al.
LUPUS (2007)
Current causes of death in systemic lupus erythematosus in Europe, 2000-2004: relation to disease activity and damage accrual
J. Nossent et al.
LUPUS (2007)
Mortality in systemic lupus erythematosus
S. Bernatsky et al.
ARTHRITIS AND RHEUMATISM (2006)
Accelerated atherosclerosis, immune response and autoimmune rheumatic diseases
LJ Jara et al.
AUTOIMMUNITY REVIEWS (2006)
Mechanisms of disease: atherosclerosis in autoimmune diseases
Y Sherer et al.
NATURE CLINICAL PRACTICE RHEUMATOLOGY (2006)
'Not only ... but also': factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus
IN Bruce
RHEUMATOLOGY (2005)
Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study
S Yusuf et al.
LANCET (2004)
Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host
W Khovidhunkit et al.
JOURNAL OF LIPID RESEARCH (2004)
Sex and age differences in lipoprotein subclasses measured by nuclear magnetic resonance spectroscopy: The Framingham study
DS Freedman et al.
CLINICAL CHEMISTRY (2004)
Prevention of cardiovascular disease in systemic lupus erythematosus - proposed guidelines for risk factor management
J Wajed et al.
RHEUMATOLOGY (2004)
Elevated triglycerides and low levels of high-density lipoprotein as markers of disease activity in association with up-regulation of the tumor necrosis factor α/tumor necrosis factor receptor system in systemic lupus erythematosus
E Svenungsson et al.
ARTHRITIS AND RHEUMATISM (2003)
Cardiovascular risk in systemic lupus erythematosus - evidence of increased oxidative stress and dyslipidaemia
SL Nuttall et al.
RHEUMATOLOGY (2003)
Testosterone administration to men increases hepatic lipase activity and decreases HDL and LDL size in 3 wk
KL Herbst et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2003)
Subendothelial retention of atherogenic lipoproteins in early atherosclerosis
K Skålén et al.
NATURE (2002)
The liver in collagen diseases: pathologic study of 160 cases with particular reference to hepatic arteritis, primary biliary cirrhosis, autoimmune hepatitis and nodular regenerative hyperplasia of the liver
T Matsumoto et al.
LIVER (2000)
分享论文
